Viela Bio to be acquired for $3.1 billion
February 01, 2021 at 08:28 AM EST
The move comes less than three years after the Gaithersburg biotech spun out of MedImmune.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.